A Biomimetic Nanocarrier Strategy Targets Ferroptosis and Efferocytosis During Myocardial Infarction
Our results demonstrated that the cooperation between the two agents induced anti-ferroptosis effects and enhanced dead cardiomyocyte clearance by macrophage as well as anti-inflammation effects. Thus, our nanoparticle Fer-aCD47@PHMSN provides a new therapeutic strategy for targeted therapy of MI.
Authors
- Weiwei Wu (ORCID: https://orcid.org/0000-0002-5227-1553)
- Lin Song (ORCID: https://orcid.org/0000-0002-5362-6467)
- Pincheng Wang (ORCID: https://orcid.org/0009-0008-1549-0299)
- Jianxun Wang (ORCID: https://orcid.org/0000-0002-3731-6514)
- Xiaosu Yuan
- Zhonghao Zhao
Institutions
- Qingdao University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/ijn.s461212
- Citations
- 13
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 3.04